title: Clinical implications of the presence of hepatitis C virus antibodies after kidney transplantation: results of a study using second-generation assays for anti-HCV.
authors.affiliation: Department of Surgery, University of Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Tomikawa
authors.forename: H
authors.initials: H
authors.lastname: Uchida
authors.forename: T
authors.initials: T
authors.lastname: Nagao
authors.forename: Y
authors.initials: Y
authors.lastname: Beck
authors.forename: H
authors.initials: H
authors.lastname: Degawa
authors.forename: K
authors.initials: K
authors.lastname: Watanabe
authors.forename: Y
authors.initials: Y
authors.lastname: Nishimura
authors.forename: Y
authors.initials: Y
authors.lastname: Nomura
authors.forename: N
authors.initials: N
authors.lastname: Ichikawa
authors.forename: K
authors.initials: K
authors.lastname: Kikuchi
mesh_terms: D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D018937:Hepatitis C Antibodies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D012263:Ribonucleosides / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D001379:Azathioprine